Nucleoside analog: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
(Add See Also and References) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 20: | Line 20: | ||
==List of Nucleoside analoges== | ==List of Nucleoside analoges== | ||
{{#ask:[[Is DrugClass::nucleoside analoge]] |format=ul }} | {{#ask:[[Is DrugClass::nucleoside analoge]] |format=ul }} | ||
==See Also== | |||
*[[Antiretrovirals]] | |||
*[[HIV]] | |||
*[[Hepatitis B]] | |||
==References== | |||
<references/> | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 09:13, 22 March 2026
Mechanism of Action
- Nucleoside analoges are a class of antiviral medications that mimic the structure of natural nucleosides, interfering with viral DNA or RNA synthesis
- Primarily used for treatment of herpesvirus infections (e.g., HSV, VZV), HIV, hepatitis B and C, and some other viral infections
- Work by being incorporated into viral nucleic acids, leading to chain termination or mutagenesis
Adverse Effects
Common
- Nausea, vomiting, diarrhea
- Headache, fatigue
- Rash or pruritus
- Bone marrow suppression (e.g., zidovudine)
Serious
- Neurotoxicity (e.g., cidofovir, tenofovir)
- Nephrotoxicity (e.g., acyclovir in renal impairment)
- Lactic acidosis and hepatotoxicity (e.g., nucleoside reverse transcriptase inhibitors like zidovudine)
- Bone density loss (e.g., tenofovir)
- Teratogenicity (e.g., ribavirin contraindicated in pregnancy)
